SCHEMBL532946

SCHEMBL532946

Cc1cc(C)c(N2CCCC2)c(C)c1NC(=O)Cc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNQ2 O43526 7/20 0.53
KMT2A Q03164 4/20 0.53
ALDH1A1 P00352 3/20 0.53
MAPT P10636 3/20 0.53
GAA P10253 3/20 0.53
KDM4E B2RXH2 2/20 0.53
NR4A1 P22736 1/20 0.53
PKM P14618 1/20 0.53
MEN1 O00255 3/20 0.53
HPGD P15428 2/20 0.53
POLB P06746 2/20 0.53
USP2 O75604 1/20 0.53
BLM P54132 1/20 0.53
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
SLC2A1 P11166 1/20 0.51
BRPF1 P55201 2/20 0.50
CNR2 P34972 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL532041 0.84 ALDH1A1 (0.42) KCNQ2KMT2AALDH1A1MAPTGAA
SCHEMBL532849 0.81 SMN1; SMN2 (0.49) KMT2AALDH1A1MAPTGAAKDM4E
SCHEMBL532829 0.78 KMT2A (0.53) KCNQ2KMT2AALDH1A1MAPTGAA
SCHEMBL534076 0.78 POLB (0.53) KMT2AALDH1A1MAPTGAAKDM4E
SCHEMBL533064 0.78 MAPT (0.56) KMT2AALDH1A1MAPTGAAKDM4E
SCHEMBL532963 0.77 SGMS2 (0.52) KMT2AALDH1A1GAAMEN1POLB
SCHEMBL532971 0.77 MEN1 (0.44) KMT2AALDH1A1MAPTGAAKDM4E
SCHEMBL533022 0.77 MEN1 (0.52) KMT2AMAPTGAAKDM4EMEN1
SCHEMBL534054 0.77 LMNA (0.46) KMT2AALDH1A1MAPTKDM4EPKM
SCHEMBL533116 0.76 MAPT (0.46) KMT2AALDH1A1MAPTGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
WO-2004073634-A2 PHENYLENEDIAMINE UROTENSIN-II RECEPTOR ANTAGONISTS AND CCR-9 ANTAGONISTS ENCYSIVE PHARMACEUTICALS INC. (US) 2004-09-02 WO disclosed